Bode announces acquisition of Chromosomal Laboratories

Bode Technology (Bode), a leading provider of forensic DNA services, announced today the acquisition of Chromosomal Laboratories, Inc., a leading provider of DNA testing for immigration and private paternity. By adding this expertise to its portfolio of service offerings, Bode will utilize its vast international and domestic presence to provide best in class immigration paternity and private paternity testing to clients worldwide. Bode is a wholly owned subsidiary of SolutionPoint International, Inc.

“This is a great opportunity for collaboration and synergy among the SolutionPoint family of companies to increase our new immigration testing business dramatically and drive new growth for the enterprise as a whole”

"Chromosomal Laboratories has established an excellent reputation through its focus on client service, fast turnaround and high quality," said Barry Watson, CEO & President of Bode. "Their focus on immigration and paternity testing complements Bode's strengths in forensic casework and databasing and enables us to expand our domestic and international offerings. With the increased use of DNA for immigration purposes and recent changes in the marketplace, we see opportunities for significant growth."

"Having admired and respected Bode Technology as a competitor in forensics for years, I am extremely excited and proud that Chromosomal has this opportunity to join their team," said Vladimir Bolin, CEO and co-founder of Chromosomal Laboratories, Inc. "The ethics, vision, resources and leadership of the Bode team is beyond reproach and sets a solid foundation for Chromosomal's technical and market leadership in the coming years."

Chromosomal Laboratories, founded in 2004, maintains AABB accreditation for relationship testing activities and ISO 17025 accreditation in forensics. It provides relationship and forensic services both in the United States and internationally. Operating out of its state-of-the-art facility in Phoenix, AZ, Chromosomal Laboratories has provided services for samples from every state in the United States and approximately one hundred countries.

Nicole Bolin, co-founder and President of Chromosomal Laboratories, will continue as the head of the Phoenix operations working closely with Mike Cariola, Chief Operating Officer of Bode Technology. Chromosomal will continue operations in Phoenix under the name of "Chromosomal Labs • Bode Technology." It will retain its existing staff and AABB accreditation as required by US Customs and Immigration Service for immigration testing.

SolutionPoint International, Bode's parent company, and Guidepost Solutions, Bode's sister company, bring extensive relationships with attorneys of the immigration bar. "This is a great opportunity for collaboration and synergy among the SolutionPoint family of companies to increase our new immigration testing business dramatically and drive new growth for the enterprise as a whole," said Joseph Rosetti, Vice Chairman, SolutionPoint International, Inc.

Source The Bode Technology Group, Inc.